Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New differentiation-inducing vitamin D compounds from Japanese lab

March 30, 1999

U. of California reports new purine cyclin-dependent kinase inhibitors

March 30, 1999

NCI initiates pilot trial of thalidomide as adjunct in cancer therapy

March 30, 1999

Bioniche technology offers synergistic benefits in cancer therapy

March 29, 1999

Sugen's new protein tyrosine kinase inhibitors

March 26, 1999

Searle characterizes new vitronectin antagonist with antitumor activity at ACS meeting

March 25, 1999

MethylGene initiates phase I clinical trials of MG-98 for solid tumors

March 25, 1999

DuPont presents 4-aminoquinazoline cyclin-dependent kinase inhibitors

March 24, 1999

High-affinity RARalpha receptor agonists reported by Eisai at ACS meeting

March 24, 1999

NCI scientists evaluate MMP inhibitor from CollaGenex

March 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...